205 related articles for article (PubMed ID: 28685896)
1. Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients.
Wollschläger D; Meng X; Wöckel A; Janni W; Kreienberg R; Blettner M; Schwentner L
Breast J; 2018 Mar; 24(2):120-127. PubMed ID: 28685896
[TBL] [Abstract][Full Text] [Related]
2. Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study.
Schwentner L; Wolters R; Koretz K; Wischnewsky MB; Kreienberg R; Rottscholl R; Wöckel A
Breast Cancer Res Treat; 2012 Apr; 132(3):1073-80. PubMed ID: 22205141
[TBL] [Abstract][Full Text] [Related]
3. Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer.
Kimmick GG; Li X; Fleming ST; Sabatino SA; Wilson JF; Lipscomb J; Cress R; Bergom C; Anderson RT; Wu XC;
J Geriatr Oncol; 2018 May; 9(3):214-220. PubMed ID: 29174187
[TBL] [Abstract][Full Text] [Related]
4. Aggressive Intrinsic Subtypes in Breast Cancer: A Predictor of Guideline Adherence in Older Patients With Breast Cancer?
Ebner F; Hancke K; Blettner M; Schwentner L; Wöckel A; Kreienberg R; Janni W; van Ewijk R
Clin Breast Cancer; 2015 Aug; 15(4):e189-95. PubMed ID: 25913904
[TBL] [Abstract][Full Text] [Related]
5. Participation in adjuvant clinical breast cancer trials: does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9,433 patients.
Schwentner L; Van Ewijk R; Kurzeder C; Hoffmann I; König J; Kreienberg R; Blettner M; Wöckel A
Eur J Cancer; 2013 Feb; 49(3):553-63. PubMed ID: 22959469
[TBL] [Abstract][Full Text] [Related]
6. The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects.
Wöckel A; Wolters R; Wiegel T; Novopashenny I; Janni W; Kreienberg R; Wischnewsky M; Schwentner L;
Ann Oncol; 2014 Mar; 25(3):628-632. PubMed ID: 24515935
[TBL] [Abstract][Full Text] [Related]
7. Effects of guideline adherence in primary breast cancer--a 5-year multi-center cohort study of 3976 patients.
Wöckel A; Kurzeder C; Geyer V; Novasphenny I; Wolters R; Wischnewsky M; Kreienberg R; Varga D
Breast; 2010 Apr; 19(2):120-7. PubMed ID: 20117932
[TBL] [Abstract][Full Text] [Related]
8. [Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study].
Wolters R; Wöckel A; Wischnewsky M; Kreienberg R
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):468-75. PubMed ID: 21843852
[TBL] [Abstract][Full Text] [Related]
9. Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients?
Varga D; Wischnewsky M; Atassi Z; Wolters R; Geyer V; Strunz K; Kreienberg R; Woeckel A
Oncology; 2010; 78(3-4):189-95. PubMed ID: 20414007
[TBL] [Abstract][Full Text] [Related]
10. Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients.
Van Ewijk R; Wöckel A; Gundelach T; Hancke K; Janni W; Singer S; Kreienberg R; Blettner M; Schwentner L
Arch Gynecol Obstet; 2015 Mar; 291(3):631-40. PubMed ID: 25178186
[TBL] [Abstract][Full Text] [Related]
11. Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients.
Schwentner L; Wolters R; Wischnewsky M; Kreienberg R; Wöckel A
Breast; 2012 Apr; 21(2):171-7. PubMed ID: 21945313
[TBL] [Abstract][Full Text] [Related]
12. Tumor biology in older breast cancer patients--what is the impact on survival stratified for guideline adherence? A retrospective multi-centre cohort study of 5378 patients.
Ebner F; van Ewijk R; Wöckel A; Hancke K; Schwentner L; Fink V; Kreienberg R; Janni W; Blettner M
Breast; 2015 Jun; 24(3):256-62. PubMed ID: 25769974
[TBL] [Abstract][Full Text] [Related]
13. Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study.
Hancke K; Denkinger MD; König J; Kurzeder C; Wöckel A; Herr D; Blettner M; Kreienberg R
Ann Oncol; 2010 Apr; 21(4):748-753. PubMed ID: 19825884
[TBL] [Abstract][Full Text] [Related]
14. Assessing the impact of CMF-like/Anthracycline-based/Anthracycline-Taxane-based/dose-dense chemotherapy in dependency of positive axillary lymph nodes/hormone receptor-status/grading/T-stage on survival - A retrospective multi-centre cohort study of 3677 patients receiving adjuvant chemotherapy.
Schwentner L; Wöckel A; König J; Janni W; Blettner M; Kreienberg R; Van Ewijk R;
Eur J Cancer; 2014 Nov; 50(17):2905-15. PubMed ID: 25239681
[TBL] [Abstract][Full Text] [Related]
15. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
Pfaendler KS; Chang J; Ziogas A; Bristow RE; Penner KR
Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
[TBL] [Abstract][Full Text] [Related]
16. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
[TBL] [Abstract][Full Text] [Related]
17. Adherence to treatment guidelines and survival in older women with early-stage breast cancer in Denmark 2008-2012.
Vogsen M; Bille C; Jylling AMB; Jensen MB; Ewertz M;
Acta Oncol; 2020 Jul; 59(7):741-747. PubMed ID: 32364416
[No Abstract] [Full Text] [Related]
18. Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy-results from the prospective multi-center study BRENDA II.
Schwentner L; Van Ewijk R; Kühn T; Flock F; Felberbaum R; Blettner M; Kreienberg R; Janni W; Wöckel A; Singer S
Support Care Cancer; 2016 Jun; 24(6):2759-66. PubMed ID: 26816089
[TBL] [Abstract][Full Text] [Related]
19. The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patients.
Jacke CO; Albert US; Kalder M
BMC Cancer; 2015 Oct; 15():734. PubMed ID: 26481452
[TBL] [Abstract][Full Text] [Related]
20. Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy-results from the prospective multi-center BRENDA II study.
Leinert E; Schwentner L; Janni W; Wöckel A; Herbert SL; Herr D; Kühn T; Flock F; Felberbaum R; Kreienberg R; Fink V; Dayan D; Ernst K; Singer S;
Breast Cancer; 2022 May; 29(3):429-436. PubMed ID: 35178667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]